VYDAC® Columns for USP and Pharmaceutical Analyses
The VYDAC SELECTAPORE™ is recommended for USP analyses. The Penicillin V
contributes stability and long column life.
analysis. Variations in selectivity based on
The specially treated base silica minimizes
tailing for alkaline analytes, and the 300 Å
pore size provides uniform surface access
for large multi-ring molecules. Performance
analyses of pharmaceuticals, on the other
hand, analytical conditions and suitability
Column: VYDAC 218WP54 (C18, 300 Å, 5 µm,4.6 mm ID x 250 mm). Detection: 254 nm.Flow: 1.0 mL/min. Mobile phase: 60:40water:ACN with 1% HOAc. Isocratic.Trisulfapyrimidines Norethindrone and ethinyl estradiol Ampicillin Column: VYDAC 218WP54 (C18, 300 Å, 5 µm,Column: VYDAC 218WP54 (C18, 300 Å, 5 µm,Column: VYDAC 218WP54 (C18, 300 Å, 5 µm,4.6 mm ID x 250 mm). Detection: 254 nm.4.6 mm ID x 250 mm). Detection: 200 nm.4.6 mm ID x 250 mm). Detection: 254 nm.Flow: 1.0 mL/min. Mobile phase: 86:13:1Flow: 1.0 mL/min. Mobile phase: 20 mMFlow: 1.0 mL/min. Mobile phase: 909:80:10:1water:ACN:glacial acetic acid. Isocratic.KH2PO4, pH 6.0, 35% ACN. Isocratic.water:ACN:1M KH2PO4 :1N acetic acid. Isocratic.b-Estradiol Prednisolone acetate Fludrocortisone Column: VYDAC 218WP54 (C18, 300 Å, 5 µm,Column: VYDAC 218WP54 (C18, 300 Å, 5 µm,Column: VYDAC 218WP54 (C18, 300 Å, 5 µm,4.6 mm ID x 250 mm). Detection: 205 nm.4.6 mm ID x 250 mm). Detection: 254 nm.4.6 mm ID x 250 mm). Detection: 254 nm.Flow: 1.0 mL/min. Mobile phase: 51:49Flow: 1.0 mL/min. Mobile phase: 40% ACNFlow: 1.0 mL/min. Mobile phase: 45:55Grace Vydac is a business unit of W. R. Grace & Co.-Conn. Application Note #0102 Separation of Barbiturates on Small-Pore and Wide-Pore Reversed-Phase Columns
convulsants by exerting depressant effects
reversed for phenobarbital/butalbital and
for secobarbital/mephobarbital due to dif-
ferences in the mobile phase. Differences
The five barbiturates were also separated
differences in selectivity were observed. Ordering Information Cat. No. Description
Column. SELECTAPORE 90M. MonomericC18. 90 Å. 5 µm. 4.6 mm ID x 250 mm. Figure 2. Separation of five barbiturates on VYDAC reversed-phase columns. Columns: (a & b) VYDAC 201SP54 (monomeric C18, 90 Å, 5 µm, 4.6 mm ID x 250 mm). (c) VYDAC 238TP54
Column. Polymeric C18. 300 Å. 5 µm. 4.6 mm ID x 250 mm. (monomeric C18, 300 Å, 5 µm, 4.6 mm ID x 250 mm). (d) VYDAC 218TP54 (polymeric C18, 300 Å,5 µm, 4.6 mm ID x 250 mm). Mobile phases: (a) A = water. B = ACN. Gradient from 30% to 60% Bover 20 minutes. (b,c,&d) A = 50 mM KH2PO4, pH 2.51, 20% ACN. B = 90% ACN. Gradient from
Column. SELECTAPORE 300P. PolymericC18. 300 Å. 5 µm. 4.6 mm ID x 250 mm. To place an order, call (800) 247-0924, fax (888) 244-6610 or contact your local Grace Vydac distributor. Grace Vydac ■ 17434 Mojave Street ■ Hesperia, CA 92345 ■ www.gracevydac.com
Copyright 2002 Grace Vydac. All rights reserved. Prices and specifications subject to change without notice. VYDAC® is a registered trademark and SELECTAPORE is a trademark of The Separations Group.
[Congressional Record Volume 159, Number 41 (Wednesday, March 20, 2013)] [Senate] [Pages S2021-S2022] From the Congressional Record Online through the Government Printing Office Mr. LEAHY. Mr. President, I have been privileged to serve Vermonters for many years as a voice on foreign policy matters, and I am always reminded that my work is a reflection of the outward looking posture of the people
Rehazentrum Bad Dürrheim – Klinik Hüttenbühl der Vortrag zum Thema: Psychopharmaka Allgemeines zu Thema Psychopharmaka Antidepressiva (AD) machen nicht abhängig AD machen nur selten Gewichtsprobleme, die durch vorherige Aufklärung AD verkürzen nachweislich die depressiven Phasen und verringern damit die AD verringern bei wiederkehrenden Depressionen sehr deutlich das